Compile Data Set for Download or QSAR
Report error Found 13 Enz. Inhib. hit(s) with all data for entry = 7193
TargetTyrosine-protein kinase receptor UFO(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM180278(US9133162, Example 9)
Affinity DataIC50: 5nMpH: 7.0 T: 2°CAssay Description:Axl (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 μM KKSRGDYMTMQIG, 10 mM MgAcetate and [γ-33P-ATP] (specific activity approx. 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM180271(US9133162, Example 2)
Affinity DataIC50: 7nMpH: 7.0 T: 2°CAssay Description:Met (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 μM KKKSPGEYVNIEFG, 10 mM MgAcetate and [γ-33P-ATP] (specific activity approx. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM180273(US9133162, Example 4)
Affinity DataIC50: 10nMpH: 7.0 T: 2°CAssay Description:Met (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 μM KKKSPGEYVNIEFG, 10 mM MgAcetate and [γ-33P-ATP] (specific activity approx. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM180270(US9133162, Example 1)
Affinity DataIC50: 11nMpH: 7.0 T: 2°CAssay Description:Axl (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 μM KKSRGDYMTMQIG, 10 mM MgAcetate and [γ-33P-ATP] (specific activity approx. 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM180278(US9133162, Example 9)
Affinity DataIC50: 13nMpH: 7.0 T: 2°CAssay Description:Met (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 μM KKKSPGEYVNIEFG, 10 mM MgAcetate and [γ-33P-ATP] (specific activity approx. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM180281(US9133162, Example 12)
Affinity DataIC50: 13nMpH: 7.0 T: 2°CAssay Description:Met (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 μM KKKSPGEYVNIEFG, 10 mM MgAcetate and [γ-33P-ATP] (specific activity approx. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM180280(US9133162, Example 11)
Affinity DataIC50: 15nMpH: 7.0 T: 2°CAssay Description:Met (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 μM KKKSPGEYVNIEFG, 10 mM MgAcetate and [γ-33P-ATP] (specific activity approx. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM180273(US9133162, Example 4)
Affinity DataIC50: 17nMpH: 7.0 T: 2°CAssay Description:Axl (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 μM KKSRGDYMTMQIG, 10 mM MgAcetate and [γ-33P-ATP] (specific activity approx. 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM180270(US9133162, Example 1)
Affinity DataIC50: 19nMpH: 7.0 T: 2°CAssay Description:Met (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 μM KKKSPGEYVNIEFG, 10 mM MgAcetate and [γ-33P-ATP] (specific activity approx. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM180271(US9133162, Example 2)
Affinity DataIC50: 23nMpH: 7.0 T: 2°CAssay Description:KDR (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [γ-33P-ATP] (specific activity app...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM180283(US9133162, Example 14)
Affinity DataIC50: 27nMpH: 7.0 T: 2°CAssay Description:Met (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 μM KKKSPGEYVNIEFG, 10 mM MgAcetate and [γ-33P-ATP] (specific activity approx. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM180270(US9133162, Example 1)
Affinity DataIC50: 37nMpH: 7.0 T: 2°CAssay Description:KDR (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [γ-33P-ATP] (specific activity app...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM180273(US9133162, Example 4)
Affinity DataIC50: 40nMpH: 7.0 T: 2°CAssay Description:KDR (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [γ-33P-ATP] (specific activity app...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent